These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
230 related items for PubMed ID: 21215800
21. Cell-type-specific roles of IGF-1R and EGFR in mediating Zn2+-induced ERK1/2 and PKB phosphorylation. Pandey NR, Vardatsikos G, Mehdi MZ, Srivastava AK. J Biol Inorg Chem; 2010 Mar; 15(3):399-407. PubMed ID: 19946718 [Abstract] [Full Text] [Related]
23. Green tea (-)-epigallocatechin gallate inhibits IGF-I and IGF-II stimulation of 3T3-L1 preadipocyte mitogenesis via the 67-kDa laminin receptor, but not AMP-activated protein kinase pathway. Ku HC, Liu HS, Hung PF, Chen CL, Liu HC, Chang HH, Tsuei YW, Shih LJ, Lin CL, Lin CM, Kao YH. Mol Nutr Food Res; 2012 Apr; 56(4):580-92. PubMed ID: 22495985 [Abstract] [Full Text] [Related]
24. Antidepressants activate the lysophosphatidic acid receptor LPA(1) to induce insulin-like growth factor-I receptor transactivation, stimulation of ERK1/2 signaling and cell proliferation in CHO-K1 fibroblasts. Olianas MC, Dedoni S, Onali P. Biochem Pharmacol; 2015 Jun 15; 95(4):311-23. PubMed ID: 25888927 [Abstract] [Full Text] [Related]
25. Coupling of the insulin-like growth factor-I receptor tyrosine kinase to Gi2 in human intestinal smooth muscle: Gbetagamma -dependent mitogen-activated protein kinase activation and growth. Kuemmerle JF, Murthy KS. J Biol Chem; 2001 Mar 09; 276(10):7187-94. PubMed ID: 11120746 [Abstract] [Full Text] [Related]
27. Differential signaling activation by insulin and insulin-like growth factors I and II upon binding to insulin receptor isoform A. Sacco A, Morcavallo A, Pandini G, Vigneri R, Belfiore A. Endocrinology; 2009 Aug 01; 150(8):3594-602. PubMed ID: 19443570 [Abstract] [Full Text] [Related]
28. Role of heterotrimeric G protein and calcium in cardiomyocyte hypertrophy induced by IGF-1. Carrasco L, Cea P, Rocco P, Peña-Oyarzún D, Rivera-Mejias P, Sotomayor-Flores C, Quiroga C, Criollo A, Ibarra C, Chiong M, Lavandero S. J Cell Biochem; 2014 Apr 01; 115(4):712-20. PubMed ID: 24243530 [Abstract] [Full Text] [Related]
29. Characterization of insulin and insulin-like growth factor-I actions in the bovine luteal cell: regulation of receptor tyrosine kinase activity, phosphatidylinositol-3-kinase, and deoxyribonucleic acid synthesis. Chakravorty A, Joslyn MI, Davis JS. Endocrinology; 1993 Sep 01; 133(3):1331-40. PubMed ID: 8396016 [Abstract] [Full Text] [Related]
30. Insulin-like growth factor-I (IGF-I)-dependent activation of pp42/44 mitogen-activated protein kinase occurs independently of IGF-I receptor kinase activation and IRS-1 tyrosine phosphorylation. Yau L, Lukes H, McDiarmid H, Werner J, Zahradka P. Eur J Biochem; 1999 Dec 01; 266(3):1147-57. PubMed ID: 10583412 [Abstract] [Full Text] [Related]
31. GIT1Y321 phosphorylation is required for ERK1/2- and PDGF-dependent VEGF secretion from osteoblasts to promote angiogenesis and bone healing. Rui Z, Li X, Fan J, Ren Y, Yuan Y, Hua Z, Zhang N, Yin G. Int J Mol Med; 2012 Oct 01; 30(4):819-25. PubMed ID: 22797318 [Abstract] [Full Text] [Related]
32. The insulin-like growth factor type 1 and insulin-like growth factor type 2/mannose-6-phosphate receptors independently regulate ERK1/2 activity in HEK293 cells. El-Shewy HM, Lee MH, Obeid LM, Jaffa AA, Luttrell LM. J Biol Chem; 2007 Sep 07; 282(36):26150-7. PubMed ID: 17620336 [Abstract] [Full Text] [Related]
33. Rho kinase-induced nuclear translocation of ERK1/ERK2 in smooth muscle cell mitogenesis caused by serotonin. Liu Y, Suzuki YJ, Day RM, Fanburg BL. Circ Res; 2004 Sep 17; 95(6):579-86. PubMed ID: 15297378 [Abstract] [Full Text] [Related]
34. Age-related differences in insulin-like growth factor-1 receptor signaling regulates Akt/FOXO3a and ERK/Fos pathways in vascular smooth muscle cells. Li M, Chiu JF, Gagne J, Fukagawa NK. J Cell Physiol; 2008 Nov 17; 217(2):377-87. PubMed ID: 18615585 [Abstract] [Full Text] [Related]
36. Differential roles of MAPK-Erk1/2 and MAPK-p38 in insulin or insulin-like growth factor-I (IGF-I) signaling pathways for progesterone production in human ovarian cells. Seto-Young D, Avtanski D, Varadinova M, Park A, Suwandhi P, Leiser A, Parikh G, Poretsky L. Horm Metab Res; 2011 Jun 17; 43(6):386-90. PubMed ID: 21448845 [Abstract] [Full Text] [Related]
37. Abnormalities of insulin-like growth factor-I signaling and impaired cell proliferation in osteoblasts from subjects with osteoporosis. Perrini S, Natalicchio A, Laviola L, Cignarelli A, Melchiorre M, De Stefano F, Caccioppoli C, Leonardini A, Martemucci S, Belsanti G, Miccoli S, Ciampolillo A, Corrado A, Cantatore FP, Giorgino R, Giorgino F. Endocrinology; 2008 Mar 17; 149(3):1302-13. PubMed ID: 18079194 [Abstract] [Full Text] [Related]
38. Delta-opioid receptors activate ERK/MAP kinase via integrin-stimulated receptor tyrosine kinases. Eisinger DA, Ammer H. Cell Signal; 2008 Dec 17; 20(12):2324-31. PubMed ID: 18804531 [Abstract] [Full Text] [Related]
39. Identification of novel signalling roles and targets for G(α) and G(βγ) downstream of the insulin-like growth factor 1 receptor in vascular smooth muscle cells. Perrault R, Zahradka P. Biochem J; 2013 Feb 15; 450(1):209-19. PubMed ID: 23186281 [Abstract] [Full Text] [Related]
40. The chemotactic and mitogenic responses of vascular smooth muscle cells to insulin-like growth factor-I require the activation of ERK1/2. Duan C. Mol Cell Endocrinol; 2003 Aug 29; 206(1-2):75-83. PubMed ID: 12943991 [Abstract] [Full Text] [Related] Page: [Previous] [Next] [New Search]